Cerca Biotech Acquires MammaTyper® for Molecular Classification of Breast Cancer
Cerca's Commercial Team Begins Worldwide Marketing of the PCR Test of MammaTyper® for Precision Subtyping of Breast Cancer FRANKFURT, GERMANY, November 10, 2021 /EINPresswire.com/ -- Cerca Biotech GmbH (“Cerca”), a Germany-based diagnostic company …